Pharmaceuticals Key Themes For 2025
Emerging markets (EMs) will outperform developed markets in terms of pharmaceutical sales growth. In 2025, global pharmaceutical sales will reach USD1.7trn, exhibiting year-on-year growth of 5.3% from 2024.
BMI Pharmaceuticals Industry Research
We help the world’s biggest pharmaceutical companies navigate risks, identify opportunities, and make better strategic decisions, especially in emerging and frontier markets.
Gauge demand for new medicines
Data and research to increase revenue-generating potential
Pharmaceuticals Research
Learn more about our research, including country specific analysis, insight into patented, generics, and OTC medicines, and assessments of global pricing and reimbursement systems.
Innovative Pharmaceuticals Risk/Reward Index
Discover our proprietary model that allows you to instantly compare the attractiveness of different countries for investment, manufacturing or sales potential.
Pharmaceutical Manufacturing Key Projects Data
Track the manufacturing activities of the world’s top pharmaceutical companies with detailed information on over 3,400 manufacturing facilities in operation, planned, or primed for expansion globally.
Latest Pharmaceuticals Indicators
From Afghanistan to Zimbabwe, our pharmaceutical dataset provides crucial data for key pharmaceutical indicators by category.
Connect with our thinking
We integrate political, macroeconomic, and cross-industry expertise into our pharmaceuticals industry analysis, allowing our customers to benefit from understanding how each factor impacts on the other in their chosen markets.
Jamie Davies
Head of Pharmaceuticals, Healthcare & Medical Devices
Amy Walker
Director
Latest Insights
Article / Asia /
Stable Outlook For Thailand’s Pharmaceutical Sector Amid Economic Constraints And Regulatory Challenges
Article / Asia /
India’s Pharmaceutical Exports Will Continue To Face Growing Challenges
Article / Vietnam /
Vietnam's Pharmaceutical Ambitions Will Be Challenged By Regulatory Hurdles And R&D Investment Gap
Article / Africa /
HoldiPharma And Dawah Pharma Joint Venture Will Boost Egypt’s Pharmaceutical Exports
Article / Asia /
Malaysia's Pharmaceutical Market Outlook Revised Upwards Post New Data Release
Article / France /
France: Sanofi Invests In Novel Alzheimer's Approach With Vigil Acquisition, Strengthening Neurology Pipeline
Article / Middle East /
Rising Burden Of Cancer In The UAE Will Pose Challenges For Health System Capacity
Article / Asia /
Drugmakers Will Continue To Navigate Trade Tensions Amid Mainland China’s Growing Influence In Pharmaceutical Innovation
Article / Global /
Oncology M&A Deals To Focus On Smaller Asset-Driven Agreements In 2025 Due To Uncertainty In Pharmaceutical Markets
Article / Asia /
Australia's Re-Elected Government Will Intensify Focus On Medicine Affordability, Challenging Drugmakers
Article / North America /
Trump’s Executive Order Seeks To Boost US Drug Manufacturing
Article / Asia /
South Korea’s Pharmaceutical Sector Will Face Moderate Risks Due To Trump's Tariff Policies
Events
AI & Its Impact On Global Labour Markets
Feb 19, 2025
Webinar | 09:00 New York EST | 14:00 London GMT
Trump’s Trade Tariffs: Global And Regional Implications, And Scenarios
Feb 04, 2025
Webinar | 10:00 New York EDT | 15:00 London GMT
Pharmaceuticals, Medical Devices & Healthcare Key Themes For 2025
Jan 16, 2025
Webinar | 16:00 Asia-Pacific SGT | 12:00 Middle East GST | 09:30 Americas EST | 14:30 Europe GMT
World of Worries: Political Risks in 2025
Oct 09, 2024
Virtual Event
Long Reads
Tariff Implications for Global Sectors & Regions
BMI’s special report analyzes reduced uncertainty after US-China de-escalation and a US-UK trade deal, but highlights ongoing risks. It examines the impact of US trade policies, with Asia most exposed to tariffs, while Mexico and Canada benefit. The report also explores how Europe and MENA adapt to new challenges and includes insights on sector risks, growth forecasts, and geopolitical and ESG impacts of trade tensions.
Asia Pacific Pharma & Healthcare Insight (May 2024)
The Asia-Pacific (APAC) region is emerging as a dynamic landscape of innovation and progress in the field of rare disease treatment, heralding a new era of possibilities for patients who have historically grappled with a scarcity of therapeutic alternatives.
RELATED PRODUCTS
You may also be interested in:
BMI Healthcare Industry Research
Data-driven analysis of healthcare systems, resources, expenditure, and digital health strategies.
BMI Medical Devices Industry Research
Strategic insight into global cardiovascular devices, in-vitro diagnostics, orthopaedics, and drug delivery markets.
BMI Advisory
Tailored research and risk management analytics, to guide your critical business decisions.
BMI Country Risk
Expert analysis of the political and economic risks that could impact your growth strategies in more than 200 markets.
BMI Operational Risk
Detailed analysis of business environment risks and comparable data evaluating the ease of doing business in world markets.
Fitch Ratings Credit Research
Quickly and thoroughly evaluate the creditworthiness of a company, country, or security with timely, independent credit research from Fitch Ratings.
Fitch Credit Ratings Data
Make better investment and credit risk decisions with Fitch Ratings multi award-winning credit ratings data.
Fitch Ratings ESG Relevance Scores Data
Price ESG risk accurately for fixed income credit assessments, with access to data on 10,000+ entities and transactions globally.
Seize opportunities in pharmaceuticals markets
Request a demonstration of Pharmaceuticals Industry Research to find out how we can help you uncover the best market opportunities for new medicines.
Once you complete the form, one of our specialists will be in touch to discuss how our data and research can be seamlessly delivered to match your needs.
